B-Raf inhibitor,
1315330-11-0,
TAK1/MAP4K2 inhibitor 1,
B-Rafinhibitor,
B-Raf inhibitor (BenzaMide),
SCHEMBL14689441,
KS-00001EMG,
DTXSID80744258,
C29H31F3N6O2,
BCP21395,
EX-A2631,
5844AA,
AKOS016012030,
ZINC100070334,
CS-1099,
NCGC00378847-01,
HY-77251,
AX8247018,
A14371,
W-5954,
BenzaMide, N-[4-[(4-ethyl-1-piperazinyl)Methyl]-3-(trifluoroMethyl)phenyl]-4-Methyl-3-[(6-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-yl)oxy]-,
N-{4-[(4-Ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl}-4-methyl-3-[(6-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy]benzamide,
N-{4-[(4-Ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}-4-methyl-3-[(6-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy]benzamide,
Benzamide,
A3264,